Indications
Therapeutic Asset Ratings
6,305 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Tislelizumab
Refractory Malignant Neoplasm
Tongji Hospital
P1/2
CC
(47)
Tivozanib
Bile Duct Cancer
University of Florida
P1/2
CC
(47)
Tivozanib
Gallbladder Cancer
University of Florida
P1/2
CC
(47)
Tivozanib
Vulva Cancer
University of Florida
P1/2
CC
(47)
tng348
Hereditary Breast Carcinoma
Tango Therapeutics, Inc.
P1/2
CC
(47)
Tocilizumab
Nasopharyngeal Carcinoma
Takeda
P1/2
CC
(47)
Tolinapant
Fallopian Tube Carcinoma
National Cancer Institute (NCI)
P1/2
CC
(47)
Tolinapant
Ovarian Carcinoma
National Cancer Institute (NCI)
P1/2
CC
(47)
Tolinapant
Primary Peritoneal Carcinoma
National Cancer Institute (NCI)
P1/2
CC
(47)
Tolinapant
Fallopian Tube Clear Cell Adenocarcinoma
National Cancer Institute (NCI)
P1/2
CC
(47)
Tolinapant
Fallopian Tube Serous Adenocarcinoma
National Cancer Institute (NCI)
P1/2
CC
(47)
Tolinapant
Ovarian Clear Cell Adenocarcinoma
National Cancer Institute (NCI)
P1/2
CC
(47)
Tolinapant
Ovarian Serous Adenocarcinoma
National Cancer Institute (NCI)
P1/2
CC
(47)
Tolinapant
Undifferentiated Ovarian Carcinoma
National Cancer Institute (NCI)
P1/2
CC
(47)
Toripalimab
Dedifferentiated Liposarcoma
STORM Therapeutics LTD
P1/2
CC
(47)
Toripalimab
Leiomyosarcoma
STORM Therapeutics LTD
P1/2
CC
(47)
Toripalimab
Liposarcoma
Ascentage Pharma Group Inc.
P1/2
CC
(47)
Torvutatug Samrotecan
Squamous Cell Lung Carcinoma
AstraZeneca
P1/2
CC
(47)
TQB2930 for injection
Cancer
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
P1/2
CC
(47)
tqb3616
Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
P1/2
CC
(47)
Trastuzumab Deruxtecan
Soft Tissue Sarcoma
GI Innovation, Inc.
P1/2
CC
(47)
Trastuzumab Deruxtecan
Lung Cancer
National Cancer Institute (NCI)
P1/2
CC
(47)
Trastuzumab Deruxtecan
Malignant Pancreatic Neoplasm
National Cancer Institute (NCI)
P1/2
CC
(47)
Trastuzumab Emtansine
Gastric Adenocarcinoma
Boehringer Ingelheim
P1/2
CC
(47)
Trop2-Car-Nk
Adenocarcinoma
M.D. Anderson Cancer Center
P1/2
CC
(47)
Showing 2676 to 2700 of 6,305 assets
Previous
Page 108 of 253
Next